Literature DB >> 9593555

What have we learned from the calcium channel blocker controversy?

R M Califf, J M Kramer.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9593555     DOI： 10.1161/01.cir.97.16.1529

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  2 in total

Review 1.  Cost per millimeter of mercury lowering is a measure of economic value for antihypertensive agents.

Authors:  R S Chen; P Lapuerta
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

2.  Portfolio of clinical research in adult cardiovascular disease as reflected in ClinicalTrials.gov.

Authors:  Karen P Alexander; David F Kong; Aijing Z Starr; Judith Kramer; Karen Chiswell; Asba Tasneem; Robert M Califf
Journal:  J Am Heart Assoc       Date:  2013-09-26       Impact factor: 5.501
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.